Replies to post #68519 on Biotech Values

[genisi]

Boehringer Ingelheim's poster presented at AASLD 2008

http://www.hivandhepatitis.com/2008icr/aasld/posters/BI_AASLD_TN_Poster_FINAL.pdf

Phase IIb study (started Oct. 08)

http://clinicaltrials.gov/ct2/show/NCT00774397?term=BI+201335&rank=1